“Crohns disease”的搜索结果，显示 1001-1010 项，共有 6886 项
The purpose of this study ia to determine the safety and tolerability of personalized neoantigen peptide administered in combination with pembrolizumab to ...
... and/or chronic GVHD (cGVHD) that requires systemic immunosuppression and to compare the disease free survival (DFS) (from time of randomization) in children and ...
A Study to Evaluate Quantitative Phenotypes of Movement Disorders. Jacksonville, Fla. The purpose of this study is to determine if adaptive rhythmic auditory ...
Mitchell EL, et al. Noninvasive diagnosis of upper and lower extremity arterial disease. https://www.uptodate.com/contents/search. Accessed May 13, 2022 ...
The objectives of this study are to determine the Maximum Tolerated Dose (MTD) and the Recommended Phase 2 Dose (RP2D) of NMS-03305293 in combination with ...
This randomized phase III trial compares memantine hydrochloride and whole-brain radiotherapy with or without hippocampal avoidance in reducing neurocognitive ...
Hirschsprungs disease. 一份馈赠，无穷力量——今天就来伸出援手！ 慷慨捐赠. 您的捐赠可以抵税。请您慷慨解囊，和我们一起进行尖端研究和医护，共同推动医学的改变。
一份馈赠，无穷力量——今天就来伸出援手！ ... 您的捐赠可以抵税。请您慷慨解囊，和我们一起进行尖端研究和医护，共同推动医学的改变。
The purpose of this study is to determine the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) of WSD0922-FU in subjects with ...
... and percent change in levels of ctDNA concentration before and after neoadjuvant therapy. ... disease has not progressed following definitive platinum-based ...
妙佑医疗国际不为任何公司或产品背书。广告收入为我们的非营利使命提供支持。
浏览妙佑医疗国际出版社提供的畅销书以及书籍和简报的特别优惠。
您的捐赠可以抵税。请您慷慨解囊，和我们一起进行尖端研究和医护，共同推动医学的改变。